The pro-inflammatory activity of Th17 lymphocytes is confirmed by the high concentration of IL-22 in the plasma of MASLD patients compared to the control group, and in patients with advanced MASLD compared to early MASLD. The gene discussed is IL22; the disease is metabolic dysfunction-associated steatotic liver disease.